CAS SciFinder Discovery Platform Expands into Biopharma
Biopharma is poised to lead the growth of the pharmaceutical and chemical development market. CAS SciFindern can now act as a single data source for chemists and bioscientists.
Read more on the Outsell Leadership Community Platform: CAS SciFinder Discovery Platform Expands into Biopharma
Author: Tatiana Khayrullina
Date: March 16, 2022
Outsell Client?
Login to access and download your reports.
———————————————–
Outsell analysis is available to clients only. To learn more about our services and investment options, please let us know how best to reach you, and we will be in touch within 24 hours.
We won’t use your info any further without your permission.
Have a great day!
———————————————–